- Info
- Significant Ownership
- Insider Ownership
Significant Ownership of Vivo Capital IX, LLC
- Signature - Title
- /s/ Frank Kung - Frank Kung/Managing Member
- Location
- Palo Alto, CA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Vivo Capital IX, LLC.
Follow Filing Activity
Follow Vivo Capital IX, LLC and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Vivo Capital IX, LLC
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SVA | Sinovac Biotech Ltd. | Common Shares, $0.001 par value per share | 6.3% | $293,522,587 | 4,539,456 | Vivo Capital IX, LLC | 17 Mar 2025 | ||
| TIL | Instil Bio, Inc. | Common stock, par value $ 0.000001 per share | 4.5% | $7,169,276 | 292,743 | Vivo Capital IX, LLC | 30 Jun 2025 | ||
| SERA | Sera Prognostics, Inc. | Class A common stock, par value $ 0.0001 per share | 4.5% | $5,528,974 | 1,650,440 | Vivo Capital IX, LLC | 31 Mar 2025 | ||
| IOBT | IO Biotech, Inc. | Common stock, par value $0.001 per share | 0% | $0 | 0 | Vivo Capital IX, LLC | 30 Sep 2025 |
Schedules 13D/G Reported by Vivo Capital IX, LLC:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.